Compared with ever-smokers, tumors of never-smokers LC patients appear to be less immunogenic [5], with less infiltrating CD8 T cells [6], fewer neoplastic cells expressing programmed death-ligand 1 (PD-L1) and lower tumor mutational burden (TMB) [7,8]. The gene discussed is CD274; the disease is laryngotracheoesophageal cleft.